Ignite Proteomics offers the only commercially available and clinically validated assay that measures both the expression and ...
Ignite Proteomics announces the publication of a significant study in the British Journal of Cancer titled “Functional activation of the ...
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
Adjuvant treatment with 160 mg aspirin daily for three years cuts recurrence rates in patients with colorectal cancer with ...
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation ...
The research indicated that deguelin's ability to enhance PTEN and KLF4 expression could ... forming new tumors. Signaling Pathways: Complex networks of molecules in a cell that work together ...
AZoLifeSciences on MSN12d
Why 3D Tumoroid Models Are the Future of Cancer ResearchD tumoroid models transform cancer research, accurately reflecting tumor biology and enabling effective drug testing and ...
Results of a study led by the Vall d'Hebron Institute of Oncology (VHIO) support the feasibility of using RAD51 testing to ...
In trastuzumab resistant cells, PTEN function is lost; thus, Akt is constitutively active. Also, resistant cells can harbor activating mutations in PI3K or Akt, which can trigger other downstream ...
FIGURE 2. Rho GTPase signaling pathways regulating neuronal survival. Rho activates a downstream ROCK/PTEN pathway that indirectly inactivates the pro-survival protein Akt to suppress neuronal ...
Monoallelic loss of PTEN and ARID1A is identified in normal colonic epithelium. The resulting haploinsufficient phenotypes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback